We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LVTX market cap is 89.12M. The company's latest EPS is USD -1.2137 and P/E is -2.88.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 15.26M | 2.64M | 1.22M | 5.14M | 53k |
Operating Income | -4.73M | -11.56M | -13.54M | -13.55M | -18.31M |
Net Income | 997k | -15M | -13.94M | -12.7M | -8.84M |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 3.5M | 5.35M | 19.39M |
Operating Income | -9.58M | -14.92M | -43.61M | -34.84M |
Net Income | -9.69M | -15.51M | -42.36M | -31.91M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 149.89M | 143.43M | 135.28M | 122.54M | 111.02M |
Total Liabilities | 57.23M | 57.39M | 60.01M | 58.65M | 56.42M |
Total Equity | 92.66M | 86.04M | 75.28M | 63.89M | 54.6M |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 8.8M | 20.49M | 139.25M | 143.43M |
Total Liabilities | 2.95M | 12.87M | 20.88M | 57.39M |
Total Equity | 5.84M | 7.62M | 118.37M | 86.04M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | -31.69M | 4.04M | -8.34M | -21.4M | -28.85M |
Investing | 13.49M | 9.35M | 7.68M | 7.9M | -8.95M |
Financing | 299k | 283k | -97k | -254k | -391k |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -8.62M | -9.31M | -28.65M | 4.04M |
Investing | -792k | -502k | -43.55M | 9.35M |
Financing | 1.18M | 18.97M | 151.16M | 283k |
Market Cap | 89.12M |
Price to Earnings Ratio | -2.88 |
Price to Sales Ratio | 4.73 |
Price to Cash Ratio | 0.91 |
Price to Book Ratio | 1.07 |
Dividend Yield | - |
Shares Outstanding | 26.29M |
Average Volume (1 week) | 452.38k |
Average Volume (1 Month) | 3.08M |
52 Week Change | 109.26% |
52 Week High | 6.47 |
52 Week Low | 1.131 |
Spread (Intraday) | 0.04 (1.17%) |
Company Name | LAVA Therapeutics NV |
Address |
yalelaan 62 utrecht, utrecht 3584 CM |
Website | https://www.lavatherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions